OpenAI and Anthropic Push Toward IPO, Expanding AI in Healthcare

According to foreign media reports, two major AI players—OpenAI and Anthropic—have officially moved toward initial public offerings (IPOs) while continuing to expand their presence in the healthcare sector. Just last week, Anthropic confidentially submitted a draft S-1 registration statement to the U.S. Securities and Exchange Commission (SEC) for a proposed initial public offering of common stock. Meanwhile, OpenAI CEO Sam Altman recently told employees that he expects the company to go public within the next year, seeking a valuation of up to $1 trillion in its IPO.

In the healthcare space, these potential IPOs could provide a clearer picture of how both companies are commercializing AI tools within regulated markets. Currently, OpenAI's and Anthropic's tools are gradually being integrated into the workflows of hospitals, health systems, payers, clinicians, and pharmaceutical companies. The IPO process will force them to disclose more financial details, revealing their actual revenue models and compliance strategies for AI applications in clinical decision support, drug discovery, patient communication, and other scenarios.

Notably, following the footsteps of AI firms, health-tracking ring maker Oura also confidentially filed its S-1 with the SEC in May of this year, planning to launch an IPO. This signals that the IPO window for health tech may be opening. As regulatory clarity improves, more AI and health-focused companies are expected to seek public listings to attract investors interested in their growth potential within the trillion-dollar healthcare market.

Editor’s Note: The IPO moves of OpenAI and Anthropic not only mark an acceleration of capital formation in the AI industry, but may also push AI applications in healthcare from "proof of concept" toward "scalable profitability." Post-IPO disclosures will help the market assess the real-world value of AI in clinical settings and provide valuation benchmarks for other startups.